Form 4 for CVNA Carvana
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001700538-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-10 | 2025-12-08 | CVNA | GILL DANIEL J. | Chief Product Off | M - OptEx | $56.24 | +80.0K | 271.1K | +42% | +$4.50M |
| DM | 2025-12-10 | 2025-12-08 | CVNA | GILL DANIEL J. | Chief Product Off | S - Sale+OE | $439.50 | -80.0K | 191.1K | -30% | -$35.16M |
| DM | 2025-12-10 | 2025-12-08 | CVNA | GILL DANIEL J. | Chief Product Off | M - OptEx | $0.00 | -80.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-08 | M | A | 34,826 | $10.07 | 225,932 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 2 | Common | Class A Common Stock | 2025-12-08 | M | A | 25,283 | $42.03 | 251,215 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 3 | Common | Class A Common Stock | 2025-12-08 | M | A | 9,597 | $51.97 | 260,812 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 4 | Common | Class A Common Stock | 2025-12-08 | M | A | 2,715 | $126.40 | 263,527 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 5 | Common | Class A Common Stock | 2025-12-08 | M | A | 7,579 | $296.05 | 271,106 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 6 | Common | Class A Common Stock | 2025-12-08 | S | D | 40,000 | $429.00 | 231,106 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 7 | Common | Class A Common Stock | 2025-12-08 | S | D | 40,000 | $450.00 | 191,106 | D | — | — | (F1) The reported option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024 (the "10b5-1 Plan"). |
| 8 | Derivative | Stock Options (Right to Buy) | 2025-12-08 | M | D | 2,715 | $0.00 | 9,051 | D | $126.40 · 2023-04-01 to 2032-02-21 | 2,715 Class A Common Stock | (F5) The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vested 25% on April 1, 2023 and monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer. |
| 9 | Derivative | Stock Options (Right to Buy) | 2025-12-08 | M | D | 9,597 | $0.00 | 56,211 | D | $51.97 · 2025-04-01 to 2034-02-13 | 9,597 Class A Common Stock | (F4) The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vests 25% on April 1, 2025 and monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer. |
| 10 | Derivative | Stock Options (Right to Buy) | 2025-12-08 | M | D | 25,283 | $0.00 | 61,401 | D | $42.03 · 2025-04-01 to 2034-01-24 | 25,283 Class A Common Stock | (F3) The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vest 25% on April 1, 2025 and monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer. |
| 11 | Derivative | Stock Options (Right to Buy) | 2025-12-08 | M | D | 34,826 | $0.00 | 200,902 | D | $10.07 · 2024-04-01 to 2033-02-22 | 34,826 Class A Common Stock | (F2) The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vested 25% on April 1, 2024 and monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer. |
| 12 | Derivative | Stock Options (Right to Buy) | 2025-12-08 | M | D | 7,579 | $0.00 | 0 | D | $296.05 · 2022-04-01 to 2031-02-17 | 7,579 Class A Common Stock | (F6) The non-qualified stock options representing the right to purchase for the exercise price Class A Common Stock of the Issuer vested 25% on April 1, 2022 and monthly thereafter for the following three years, subject to the Reporting Person's continued service with the Issuer. |